COLUMBIA, Md., May 22 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its second fiscal quarter on June 6, 2006, at approximately 4:00 p.m. Eastern Daylight Time (EDT). Following the release, at 4:45 p.m. EDT Martek will hold a conference call to discuss its second quarter results with investors. The call is expected to be approximately one hour in duration.
The conference call will also be available live via the Internet. All interested parties may listen to the call by visiting Martek’s web site at http://www.martekbio.com, selecting the “Investors” tab, choosing “Live Webcast” and then following the related instructions.
An archive of the conference call will be available on Martek’s website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-558-5253 and entering passcode 21292198.
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
CONTACT: Kyle Stults, Investor Relations of Martek Biosciences Corporation, +1-410-740-0081.
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations of Martek BiosciencesCorporation, +1-410-740-0081
